Marat Sultanov
Biographic Data
| ID | 7756720 |
|---|---|
| NAME | Marat Sultanov |
| GIVEN NAMES | Marat |
| FAMILY NAME | Sultanov |
| SIGNATURE | SULTANOV M |
| AFFILIATIONS | University Medical Center Groningen |
| ORCID | 0000-0002-5746-811X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
High-risk human papillomavirus testing for underscreened populations
The provided estimates can serve to inform policymakers and researchers in the context of implementing hrHPV-based screening in diverse settings
Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda
Background: Uganda has a high burden of cervical cancer and its current coverage of screening based on visual inspection with acetic acid (VIA) is low. High-risk HPV (hrHPV) testing is recommended by the World Health Organization as part of the global elimination strategy for cervical cancer. In this context, country-specific health economic evaluations can inform national-level decisions regarding implementation. We evaluated the recommended hrH…
Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations
ClinicalTrials.gov, NCT05234112 . Registered 10 February 2022
No prominent works on this page.
Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations
ClinicalTrials.gov, NCT05234112 . Registered 10 February 2022
Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda
Background: Uganda has a high burden of cervical cancer and its current coverage of screening based on visual inspection with acetic acid (VIA) is low. High-risk HPV (hrHPV) testing is recommended by the World Health Organization as part of the global elimination strategy for cervical cancer. In this context, country-specific health economic evaluations can inform national-level decisions regarding implementation. We evaluated the recommended hrH…
High-risk human papillomavirus testing for underscreened populations
The provided estimates can serve to inform policymakers and researchers in the context of implementing hrHPV-based screening in diverse settings
Cervical Cancer and HPV Research (3 works) · Global Cancer Incidence and Screening (3 works) · Medicine (3 works) · Biostatistics (2 works) · Cancer (2 works) · Cervical cancer (2 works) · Nursing (2 works) · Public health (2 works) · Alternative medicine (1 work) · Biology (1 work)